Annual long term debt:
$18.33B-$1.05B(-5.43%)Summary
- As of today (September 18, 2025), GSK annual long term debt is $18.33 billion, with the most recent change of -$1.05 billion (-5.43%) on December 31, 2024.
- During the last 3 years, GSK annual long term debt has fallen by -$9.53 billion (-34.21%).
- GSK annual long term debt is now -42.75% below its all-time high of $32.02 billion, reached on December 31, 2020.
Performance
GSK Long term debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly long term debt:
$20.97B-$291.98M(-1.37%)Summary
- As of today (September 18, 2025), GSK quarterly long term debt is $20.97 billion, with the most recent change of -$291.98 million (-1.37%) on June 30, 2025.
- Over the past year, GSK quarterly long term debt has increased by +$3.81 billion (+22.19%).
- GSK quarterly long term debt is now -35.41% below its all-time high of $32.47 billion, reached on June 30, 2018.
Performance
GSK Quarterly long term debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Long term debt Formula
Long-Term Debt = Bonds Payable + Long-Term Loans + Mortgage Payable + Other Long-Term Borrowings − Current Portion of Long-Term Debt
GSK Long term debt Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -5.4% | +22.2% |
| 3 y3 years | -34.2% | -8.1% |
| 5 y5 years | -41.3% | -34.0% |
GSK Long term debt Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -34.2% | at low | -8.1% | +22.2% |
| 5 y | 5-year | -42.8% | at low | -34.5% | +22.2% |
| alltime | all time | -42.8% | >+9999.0% | -35.4% | >+9999.0% |
GSK Long term debt History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $20.97B(-1.4%) |
| Mar 2025 | - | $21.26B(+16.0%) |
| Dec 2024 | $18.33B(-5.4%) | $18.33B(+3.2%) |
| Sep 2024 | - | $17.76B(+3.5%) |
| Jun 2024 | - | $17.16B(-10.4%) |
| Mar 2024 | - | $19.15B(-1.2%) |
| Dec 2023 | $19.38B(-5.4%) | $19.38B(-0.7%) |
| Sep 2023 | - | $19.52B(-1.3%) |
| Jun 2023 | - | $19.77B(-3.9%) |
| Mar 2023 | - | $20.58B(+0.4%) |
| Dec 2022 | $20.49B(-26.5%) | $20.49B(-5.0%) |
| Sep 2022 | - | $21.57B(-5.4%) |
| Jun 2022 | - | $22.81B(+1.7%) |
| Mar 2022 | - | $22.43B(-19.5%) |
| Dec 2021 | $27.86B(-13.0%) | $27.86B(-0.3%) |
| Sep 2021 | - | $27.96B(-1.0%) |
| Jun 2021 | - | $28.24B(-11.2%) |
| Mar 2021 | - | $31.80B(-0.7%) |
| Dec 2020 | $32.02B(+2.5%) | $32.02B(+6.1%) |
| Sep 2020 | - | $30.17B(-5.1%) |
| Jun 2020 | - | $31.79B(+3.6%) |
| Mar 2020 | - | $30.68B(-1.8%) |
| Dec 2019 | $31.25B(+21.0%) | $31.25B(+2.1%) |
| Sep 2019 | - | $30.60B(+3.1%) |
| Jun 2019 | - | $29.67B(-2.5%) |
| Mar 2019 | - | $30.42B(+17.8%) |
| Dec 2018 | $25.82B(+33.8%) | $25.82B(-20.2%) |
| Sep 2018 | - | $32.35B(-0.4%) |
| Jun 2018 | - | $32.47B(+65.1%) |
| Mar 2018 | - | $19.66B(+1.9%) |
| Dec 2017 | $19.30B(+6.5%) | $19.30B(+0.6%) |
| Sep 2017 | - | $19.18B(+20.4%) |
| Jun 2017 | - | $15.92B(-12.8%) |
| Mar 2017 | - | $18.26B(+0.8%) |
| Dec 2016 | $18.12B(-19.8%) | $18.12B(-9.4%) |
| Sep 2016 | - | $20.01B(-0.9%) |
| Jun 2016 | - | $20.18B(-10.8%) |
| Mar 2016 | - | $22.64B(+0.2%) |
| Dec 2015 | $22.59B(-8.6%) | $22.59B(-1.3%) |
| Sep 2015 | - | $22.88B(-1.0%) |
| Jun 2015 | - | $23.11B(+2.3%) |
| Mar 2015 | - | $22.60B(-8.5%) |
| Dec 2014 | $24.70B(-3.5%) | $24.70B(+11.9%) |
| Sep 2014 | - | $22.08B(-11.0%) |
| Jun 2014 | - | $24.80B(-3.3%) |
| Mar 2014 | - | $25.64B(+0.2%) |
| Dec 2013 | $25.60B(+7.3%) | $25.60B(+1.0%) |
| Sep 2013 | - | $25.35B(+2.6%) |
| Jun 2013 | - | $24.72B(-5.9%) |
| Mar 2013 | - | $26.27B(+10.1%) |
| Dec 2012 | $23.85B(+25.7%) | $23.85B(+10.8%) |
| Sep 2012 | - | $21.53B(+1.1%) |
| Jun 2012 | - | $21.29B(+11.1%) |
| Mar 2012 | - | $19.16B(+1.0%) |
| Dec 2011 | $18.96B(-18.2%) | $18.96B(-14.3%) |
| Sep 2011 | - | $22.13B(-3.1%) |
| Jun 2011 | - | $22.84B(-3.9%) |
| Mar 2011 | - | $23.77B(+2.5%) |
| Dec 2010 | $23.19B | $23.19B(-0.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2010 | - | $23.40B(+5.3%) |
| Jun 2010 | - | $22.21B(-3.8%) |
| Mar 2010 | - | $23.09B(-3.3%) |
| Dec 2009 | $23.88B(+9.0%) | $23.88B(-0.7%) |
| Sep 2009 | - | $24.05B(+11.7%) |
| Jun 2009 | - | $21.52B(-0.6%) |
| Mar 2009 | - | $21.65B(-1.1%) |
| Dec 2008 | $21.90B(+55.7%) | $21.90B(-4.0%) |
| Sep 2008 | - | $22.82B(-8.8%) |
| Jun 2008 | - | $25.01B(+55.1%) |
| Mar 2008 | - | $16.13B(+14.6%) |
| Dec 2007 | $14.07B(+50.6%) | $14.07B(+41.3%) |
| Sep 2007 | - | $9.95B(-1.2%) |
| Jun 2007 | - | $10.08B(+7.4%) |
| Mar 2007 | - | $9.39B(+0.5%) |
| Dec 2006 | $9.34B(+3.2%) | $9.34B(+3.0%) |
| Sep 2006 | - | $9.06B(+0.5%) |
| Jun 2006 | - | $9.02B(-1.6%) |
| Mar 2006 | - | $9.17B(+1.4%) |
| Dec 2005 | $9.05B(+7.6%) | $9.05B(-1.9%) |
| Sep 2005 | - | $9.22B(-1.3%) |
| Jun 2005 | - | $9.34B(+21.1%) |
| Mar 2005 | - | $7.72B(-8.3%) |
| Dec 2004 | $8.41B(+28.7%) | $8.41B(-6.5%) |
| Sep 2004 | - | $9.00B(+1.1%) |
| Jun 2004 | - | $8.90B(+34.7%) |
| Mar 2004 | - | $6.61B(+1.1%) |
| Dec 2003 | $6.54B(+31.3%) | $6.54B(+6.2%) |
| Sep 2003 | - | $6.16B(-2.7%) |
| Jun 2003 | - | $6.33B(+35.5%) |
| Mar 2003 | - | $4.67B(-6.2%) |
| Dec 2002 | $4.98B(+62.3%) | $4.98B(+17.8%) |
| Sep 2002 | - | $4.22B(+15.2%) |
| Jun 2002 | - | $3.67B(+4.3%) |
| Mar 2002 | - | $3.52B(+14.6%) |
| Dec 2001 | $3.07B(+17.3%) | $3.07B(+37.2%) |
| Sep 2001 | - | $2.24B(+1.4%) |
| Jun 2001 | - | $2.21B(-5.2%) |
| Mar 2001 | - | $2.33B(-10.9%) |
| Dec 2000 | $2.62B(-14.4%) | $2.61B(-10.1%) |
| Sep 2000 | - | $2.91B(-1.6%) |
| Jun 2000 | - | $2.95B(-2.1%) |
| Mar 2000 | - | $3.01B(+48.0%) |
| Dec 1999 | $3.06B(+1.9%) | $2.04B(-20.1%) |
| Jun 1999 | - | $2.55B(-14.5%) |
| Dec 1998 | $3.00B(-0.9%) | $2.98B(-0.3%) |
| Jun 1998 | - | $2.99B(-1.9%) |
| Dec 1997 | $3.03B(+4.2%) | $3.05B(+5.6%) |
| Dec 1996 | $2.91B(+27.7%) | $2.89B(-44.5%) |
| Dec 1995 | $2.28B(+442.1%) | - |
| Jun 1995 | - | $5.20B(+1141.0%) |
| Jun 1994 | $419.83M(+32.4%) | $419.02M(+31.0%) |
| Jun 1993 | $317.15M(+21.7%) | $319.84M(+22.9%) |
| Jun 1992 | $260.70M(+14.8%) | $260.30M(+14.6%) |
| Jun 1991 | $227.01M(+196.0%) | $227.11M(+196.1%) |
| Jun 1990 | $76.69M(+54.6%) | $76.69M(+54.6%) |
| Jun 1989 | $49.59M(+141.8%) | $49.59M(+141.8%) |
| Jun 1988 | $20.51M(-2.0%) | $20.51M(-2.0%) |
| Jun 1987 | $20.93M(+36.7%) | $20.93M(+36.7%) |
| Jun 1986 | $15.31M | $15.31M |
FAQ
- What is GSK plc annual long term debt?
- What is the all time high annual long term debt for GSK plc?
- What is GSK plc annual long term debt year-on-year change?
- What is GSK plc quarterly long term debt?
- What is the all time high quarterly long term debt for GSK plc?
- What is GSK plc quarterly long term debt year-on-year change?
What is GSK plc annual long term debt?
The current annual long term debt of GSK is $18.33B
What is the all time high annual long term debt for GSK plc?
GSK plc all-time high annual long term debt is $32.02B
What is GSK plc annual long term debt year-on-year change?
Over the past year, GSK annual long term debt has changed by -$1.05B (-5.43%)
What is GSK plc quarterly long term debt?
The current quarterly long term debt of GSK is $20.97B
What is the all time high quarterly long term debt for GSK plc?
GSK plc all-time high quarterly long term debt is $32.47B
What is GSK plc quarterly long term debt year-on-year change?
Over the past year, GSK quarterly long term debt has changed by +$3.81B (+22.19%)